The German Biobank Node (GBN), which is part of BBMRI-ERIC, asked more than 330 “potential biobank users” at university hospitals about their attitudes towards collaborating with biobanks. Here, Dr. Cornelia Specht, managing director of the GBN, tells us about the survey results and conclusions.
ISO Biobank Standards Assuring researchers as to the quality or standard of a Biobank is an important issue. We are here to keep you abreast of all the latest developments in the field. You may have heard that new ISO Biobank standards are coming soon, but who is writing them and how can you get involved? Gareth Bicknell, HBRC Operations Manager at the University of Birmingham explains more here. What… Read More »ISO Biobank Standards
Accreditation Review of the CCB’s pilot audit scheme Background Biobanking is recognised as a critical area requiring development if progress is to be made in identifying clinically useful markers of disease and disease progression, discovering new drug targets and understanding the mechanisms of disease in cancer. Researchers continue to report that they are unable to obtain sufficient high quality, well annotated samples of diseased and control tissue, blood and other… Read More »Accreditation